SeaStar Medical
21 hedge funds and large institutions have $440K invested in SeaStar Medical in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
544% more capital invested
Capital invested by funds: $68.3K → $440K (+$372K)
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
75% more funds holding
Funds holding: 12 → 21 (+9)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$155K |
| 2 |
Morgan Stanley
New York
|
+$59.2K |
| 3 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$31.1K |
| 4 |
EH
Equitable Holdings
New York
|
+$29.6K |
| 5 |
State Street
Boston,
Massachusetts
|
+$29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$4.34K |
| 2 |
HF
HRT Financial
New York
|
-$2K |
ICU Hedge Fund Activity: Q4 2023 in Review
21 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q4 2023, worth a combined $440K — up 544% from $68.3K a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ICU positions and 2 closed out — a net gain of 9 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $155K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $4.34K sold.
- 21 institutional investors held SeaStar Medical (ICU) as of Q4 2023, up from 12 in Q3 2023.
- Funds reported $440K of SeaStar Medical stock for Q4 2023, up 544% quarter-over-quarter.
- 11 funds opened new SeaStar Medical positions in Q4 2023 and 2 closed out, a net change of +9 holders.
- The largest SeaStar Medical buyer in Q4 2023 was Vanguard Group, an estimated $155K added.
- The largest SeaStar Medical seller in Q4 2023 was Warberg Asset Management, an estimated $4.34K sold.
Based on aggregated 13F filings for Q4 2023.